CD8A and neoplasm: Significant changes in tumor immune microenvironment were also reported, including the upregulation of immune checkpoints—such as PD-L1 (CD276) and NRP1—and activation of B-cells and CD8+ T-cells in invasive tumors following hypoxia [102].